Infectious properties of human immunodeficiency virus type 1 mutants with distinct affinities for the CD4 receptor
暂无分享,去创建一个
[1] K. Peden,et al. CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1 , 1997, Journal of virology.
[2] Marc Parmentier,et al. A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion Cofactors , 1996, Cell.
[3] Ying Sun,et al. The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates , 1996, Cell.
[4] C. Broder,et al. CC CKR5: A RANTES, MIP-1α, MIP-1ॆ Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1 , 1996, Science.
[5] Virginia Litwin,et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 , 1996, Nature.
[6] Stephen C. Peiper,et al. Identification of a major co-receptor for primary isolates of HIV-1 , 1996, Nature.
[7] D. Kabat,et al. Exceptional fusogenicity of Chinese hamster ovary cells with murine retroviruses suggests roles for cellular factor(s) and receptor clusters in the membrane fusion process , 1996, Journal of virology.
[8] Paul E. Kennedy,et al. HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.
[9] Ying Sun,et al. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates , 1995, Journal of virology.
[10] S. Harrison,et al. The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution , 1995, Nature.
[11] H. Schuitemaker,et al. Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera , 1995, Journal of virology.
[12] B. Chesebro,et al. Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1 , 1994, Journal of virology.
[13] M. Martin,et al. Increase in soluble CD4 binding to and CD4-induced dissociation of gp120 from virions correlates with infectivity of human immunodeficiency virus type 1 , 1994, Journal of virology.
[14] Q. Sattentau,et al. Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding , 1993, Journal of virology.
[15] E. Rieber,et al. The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure prophylaxis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[16] P. Earl,et al. Multimeric CD4 binding exhibited by human and simian immunodeficiency virus envelope protein dimers , 1992, Journal of Virology.
[17] J. L. Raina,et al. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. , 1992, Virology.
[18] K. Peden,et al. Changes in both gp120 and gp41 can account for increased growth potential and expanded host range of human immunodeficiency virus type 1 , 1992, Journal of virology.
[19] R. Schooley,et al. Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[20] E. G. Shpaer,et al. Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro , 1992, Journal of virology.
[21] J. Moore,et al. Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates , 1992, Journal of virology.
[22] R. Burgeson,et al. Plasma membrane receptors for ecotropic murine retroviruses require a limiting accessory factor , 1991, Journal of virology.
[23] J. Hoxie,et al. Cytopathic variants of an attenuated isolate of human immunodeficiency virus type 2 exhibit increased affinity for CD4 , 1991, Journal of virology.
[24] J. Sodroski,et al. Effects of changes in gp120-CD4 binding affinity on human immunodeficiency virus type 1 envelope glycoprotein function and soluble CD4 sensitivity , 1991, Journal of virology.
[25] Q. Sattentau,et al. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding , 1991, The Journal of experimental medicine.
[26] J. Spouge,et al. Blocking of human immunodeficiency virus infection depends on cell density and viral stock age , 1991, Journal of virology.
[27] H. Ellens,et al. Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[28] J. Moore,et al. Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization , 1991, Journal of virology.
[29] J. Sodroski,et al. Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding , 1990, Journal of virology.
[30] Q. Sattentau,et al. Dissociation of gp120 from HIV-1 virions induced by soluble CD4. , 1990, Science.
[31] D. Littman,et al. Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity , 1990, Journal of virology.
[32] D. Ho,et al. High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[33] J. Spouge,et al. HIV requires multiple gp120 molecules for CD4-mediated infection , 1990, Nature.
[34] J. Albert,et al. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates , 1988, Journal of virology.
[35] S. Dewhurst,et al. Differences in cytopathogenicity and host cell range among infectious molecular clones of human immunodeficiency virus type 1 simultaneously isolated from an individual , 1988, Journal of virology.
[36] David Looney,et al. Biologically diverse molecular variants within a single HIV-1 isolate , 1988, Nature.
[37] Huisman,et al. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex , 1988, Journal of virology.
[38] S. Wain-Hobson,et al. Genetic variability of the AIDS virus: Nucleotide sequence analysis of two isolates from African patients , 1986, Cell.
[39] G. Firestone,et al. Highly sensitive immunoadsorption procedure for detection of low-abundance proteins. , 1986, Analytical biochemistry.
[40] A. van der Eb,et al. A new technique for the assay of infectivity of human adenovirus 5 DNA. , 1973, Virology.
[41] J. White. 15 Fusion of Influenza Virus in Endosomes: Role of the Hemagglutinin , 1994 .
[42] B. Chesebro,et al. Use of a new CD4-positive HeLa cell clone for direct quantitation of infectious human immunodeficiency virus from blood cells of AIDS patients. , 1991, The Journal of infectious diseases.